Journal
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
Volume 712, Issue -, Pages -Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.abb.2021.109040
Keywords
SMYD; Methylation; Epigenetics; Development; Cancer
Categories
Ask authors/readers for more resources
The SMYD protein family consists of five members, with SMYD2 and SMYD3 being more extensively studied compared to the other members. Over the past five years, research has focused on basic molecular biology mechanistic studies and translational or clinical studies related to SMYD proteins.
Background: Epigenetic modifiers, such as methyltransferases, play crucial roles in the regulation of many biological processes, including development, cancer and multiple physiopathological conditions. Summary: The Su(Var)3-9, Enhancer-of-zeste and Trithorax (SET) and Myeloid, Nervy, and DEAF-1 (MYND) domain-containing (SMYD) protein family consists of five members in humans and mice (i.e. SMYD1, SMYD2, SMYD3, SMYD4 and SMYD5), which are known or predicted to have methyltransferase activity on histone and non-histone substrates. The abundance of information concerning SMYD2 and SMYD3 is of note, whereas the other members of the SMYD family have not been so thoroughly studied Conclusion: Here we review the literature regarding SMYD proteins published in the last five years, including basic molecular biology mechanistic studies using in vitro systems and animal models, as well as human studies with a more translational or clinical approach.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available